Nutrition, Microbiota and Noncommunicable Diseases
Health is defined as "the state of the organism when it functions optimally without evidence of disease". Surprisingly, the words "microbes" or "microorganism" are missing in this definition. The regulation of gut microbiota is mediated by an enormous quantity of aspect...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_68960 | ||
005 | 20210501 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210501s2020 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-03936-917-1 | ||
020 | |a 9783039369164 | ||
020 | |a 9783039369171 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-03936-917-1 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Plaza-Díaz, Julio |4 edt | |
700 | 1 | |a Plaza-Díaz, Julio |4 oth | |
245 | 1 | 0 | |a Nutrition, Microbiota and Noncommunicable Diseases |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
300 | |a 1 electronic resource (416 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Health is defined as "the state of the organism when it functions optimally without evidence of disease". Surprisingly, the words "microbes" or "microorganism" are missing in this definition. The regulation of gut microbiota is mediated by an enormous quantity of aspects, such as microbiological factors, host characteristics, diet patterns, and environmental variables. Some protective, structural, and metabolic functions have been reported for gut microbiota, and these functions are related to the regulation of homeostasis and host health. Host defense against pathogens is, in part, mediated through gut microbiota action and requires intimate interpretation of the current microenvironment and discrimination between commensal and occasional bacteria. The present Special Issue provides a summary of the progress on the topic of intestinal microbiota and its important role in human health in different populations. This Special Issue will be of great interest from a clinical and public health perspective. Nevertheless, more studies with more samples and comparable methods are necessary to understand the actual function of intestinal microbiota in disease development and health maintenance. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a sperm quality | ||
653 | |a probiotics | ||
653 | |a zebrafish | ||
653 | |a motility | ||
653 | |a behavior | ||
653 | |a intestinal microbiota | ||
653 | |a intestinal Bacteroides | ||
653 | |a cardiorespiratory fitness | ||
653 | |a trunk muscle training | ||
653 | |a aerobic exercise training | ||
653 | |a brisk walking | ||
653 | |a nutrients | ||
653 | |a gut microbiota | ||
653 | |a nutrition | ||
653 | |a habitual diets | ||
653 | |a Western diet | ||
653 | |a obesity | ||
653 | |a cardiometabolic risk factors | ||
653 | |a chronic health conditions | ||
653 | |a gastrointestinal disorders | ||
653 | |a prebiotics and probiotics | ||
653 | |a metabolic syndrome | ||
653 | |a gastrointestinal microbiome | ||
653 | |a Lactobacillus reuteri V3401 | ||
653 | |a sugar alcohol | ||
653 | |a prebiotic | ||
653 | |a bowel function | ||
653 | |a immune function | ||
653 | |a respiratory tract infections | ||
653 | |a otitis media | ||
653 | |a sinusitis | ||
653 | |a weight management | ||
653 | |a satiety | ||
653 | |a bone health | ||
653 | |a AMP-activated protein kinase | ||
653 | |a butyrate | ||
653 | |a developmental origins of health and disease (DOHaD) | ||
653 | |a high fat diet | ||
653 | |a hypertension | ||
653 | |a nutrient-sensing signals | ||
653 | |a propionate | ||
653 | |a short chain fatty acids | ||
653 | |a kefir | ||
653 | |a autism spectrum disorders | ||
653 | |a oral microbiota | ||
653 | |a dysbiosis | ||
653 | |a co-occurring conditions | ||
653 | |a allergy | ||
653 | |a abdominal pain | ||
653 | |a biomarker discovery | ||
653 | |a anorexia | ||
653 | |a food restriction | ||
653 | |a ClpB | ||
653 | |a microbiota | ||
653 | |a Enterobacteriaceae | ||
653 | |a inulin | ||
653 | |a circadian rhythm | ||
653 | |a feeding timing | ||
653 | |a choline | ||
653 | |a trimethylamine | ||
653 | |a trimethylamine n-oxide | ||
653 | |a 16S rRNA gene profiling | ||
653 | |a qPCR | ||
653 | |a linear mixed models | ||
653 | |a soy protein | ||
653 | |a lipid metabolism | ||
653 | |a circadian | ||
653 | |a chrono-nutrition | ||
653 | |a microbiome | ||
653 | |a pregnancy | ||
653 | |a fetus | ||
653 | |a placenta | ||
653 | |a newborn | ||
653 | |a infancy | ||
653 | |a critical illness | ||
653 | |a sepsis | ||
653 | |a lipid metabolome | ||
653 | |a amlodipine | ||
653 | |a corticosterone | ||
653 | |a ACTH | ||
653 | |a gut bacteriome | ||
653 | |a ischemia-reperfusion injury | ||
653 | |a nutritional status | ||
653 | |a supplemented nutrition | ||
653 | |a partial hepatectomy | ||
653 | |a liver transplantation | ||
653 | |a vaginal microbiome | ||
653 | |a bacterial communities | ||
653 | |a vaginal dysbiosis | ||
653 | |a bacterial vaginosis | ||
653 | |a risk factors | ||
653 | |a hormone replacement therapy | ||
653 | |a cardiovascular diseases | ||
653 | |a atherosclerosis | ||
653 | |a prebiotics | ||
653 | |a alanine aminotransferase | ||
653 | |a antibiotic | ||
653 | |a Optifast | ||
653 | |a gut microbiome | ||
653 | |a metronidazole | ||
653 | |a nonnutritive sweeteners | ||
653 | |a sweetening agents | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2728 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/68960 |7 0 |z DOAB: description of the publication |